Lantheus Holdings LNTH Accrued Research And Development Costs Current
Accrued Research And Development Costs Current at other companies
Other financials
Where this comes from
Reported directly by Lantheus Holdings in its filing.
Tagged under the XBRL concept lnth:AccruedResearchAndDevelopmentCostsCurrent.
The official record: Lantheus Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lantheus Holdings's accrued research and development costs current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lantheus Holdings's accrued research and development costs current?
- Lantheus Holdings (LNTH) reported accrued research and development costs current of $12.47M in Q1 2026.
- How has Lantheus Holdings's accrued research and development costs current changed year-over-year?
- Lantheus Holdings's accrued research and development costs current increased by 17.7% year-over-year, from $10.59M to $12.47M.
- What is the long-term trend for Lantheus Holdings's accrued research and development costs current?
- Over 2 years (2023 to 2025), Lantheus Holdings's accrued research and development costs current has grown at a 99.5% compound annual growth rate (CAGR), from $3.26M to $12.96M.
- What does accrued research and development costs current mean?
- This represents the accrued expenses for ongoing research and development activities that have been performed but not yet billed. It provides a window into the intensity and timing of the company's innovation pipeline and clinical trial progress. Significant changes in this metric can signal shifts in the pace of product development or R&D investment.